isradipine has been researched along with Bright Disease in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futrakul, N | 1 |
| Pochanugool, C | 1 |
| Sitprija, V | 1 |
| Singkhwa, V | 1 |
| Futrakul, P | 1 |
| Yenrudi, S | 1 |
| Sensirivatana, R | 1 |
| Watana, D | 1 |
| Poshyachinda, M | 1 |
1 other study available for isradipine and Bright Disease
| Article | Year |
|---|---|
Renal dysfunction in glomerulonephropathy associated with rapid onset renal failure.
Topics: Acute Kidney Injury; Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; An | 1997 |